Excellence in Research and Innovation for Humanity

ICICIDR 2021 : 23rd International Conference on Immunotoxicology, Cellular Immunology and Drug Rehabilitation

Zurich, Switzerland
April 20 - 21, 2021

Conference Code: 21CH04ICICIDR

International Research Conference Aims and Objectives

The ICICIDR 2021: 23rd International Conference on Immunotoxicology, Cellular Immunology and Drug Rehabilitation aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Immunotoxicology, Cellular Immunology and Drug Rehabilitation. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Immunotoxicology, Cellular Immunology and Drug Rehabilitation.

Call for Contributions

All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Immunotoxicology, Cellular Immunology and Drug Rehabilitation are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.WASET

Conference Proceedings

All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the International Science Index (ISI), Google Scholar, Semantic Scholar, Zenedo, OpenAIRE, BASE, WorldCAT, Sherpa/RoMEO, and other index databases. Impact Factor Indicators.

Special Journal Issues

ICICIDR 2021 has teamed up with the Special Journal Issue on Immunotoxicology, Cellular Immunology and Drug Rehabilitation. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.

Conference Sponsor and Exhibitor Opportunities

The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form.

Important Dates

Abstracts/Full-Text Paper Submission Deadline   June 20, 2020
Notification of Acceptance/Rejection   October 30, 2020
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline   December 6, 2020
Conference Dates   April 20 - 21, 2021

Important Notes

Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for Full-Text Papers and Abstract Papers.

Please refer to the Paper Submission GUIDE before submitting your paper.

Selected Conference Papers

1) Comparison of the Use of Vaccines or Drugs against Parasitic Diseases
H. Al-Khalaifa, A. Al-Nasser
2) The Need for Including Hepatitis a Vaccine in Routine Childhood Immunization Programs in Europe as a Response to the Influx of Refugees from the Middle East and North Africa (MENA) Regions
S. Ramia, N. Melhem, K. Kreidieh
3) Displaying of GnRH Peptides on Bacteriophage T7 and Its Immunogenicity in Mice Model
Hai Xu, Yiwei Wang, Xi Bao, Bihua Deng, Pengcheng Li, Yu Lu
4) Vaccinated Susceptible Infected and Recovered (VSIR) Mathematical Model to Study the Effect of Bacillus Calmette-Guerin (BCG) Vaccine and the Disease Stability Analysis
Muhammad Shahid, Nasir-uddin Khan, Mushtaq Hussain, Muhammad Liaquat Ali, Asif Mansoor
5) Hepatitis B Virus Infection among Egyptian Children Vaccinated during Infancy
Iman I. Salama, Samia M. Sami, Somaia I. Salama, Zeinab N. Said, Thanaa M. Rabah, Aida M. Abdel-Mohsin
6) Unnoticeable Mumps Infection in India: Does MMR Vaccine Protect against Circulating Mumps Virus Genotype C?
Jeevan Malayan, Aparna Warrier, Padmasani Venkat Ramanan, Sanjeeva Reddy N, Elanchezhiyan Manickan
7) The Influence of Heat Treatment on Antimicrobial Proteins in Milk
Jelena Zagorska, Inga Ciprovica
8) Immune Responce in Mice Immunized with Live Cold-Adapted Influenza Vaccine in Combination with Chitosan-Based Adjuvants
Nelly К. Akhmatova, Оlga V. Lebedinskaya, Ancha V. Baranova, Еlena А. Lebedinskaya, Ekaterina V. Sorokina, Elvin А. Akhmatov, Аnatoliy P. Godovalov, Stanislav G. Markushin
9) Chitosan Nanoparticle as a Novel Delivery System for A/H1n1 Influenza Vaccine: Safe Property and Immunogenicity in Mice
Nguyen Anh Dzung, Nguyen Thi Ngoc Hà, Dang Thi Hong Van, Nguyen Thi Lan Phuong, Nguyen Thi Nhu Quynh, Dinh Minh Hiep, Le Van Hiep
10) Implementation of a “DIVA“ Concept withspecific Elisa Kits; When Subunit H5 Avian Influenza Vaccine is used
Robles F, Uribe A, Guadarrama A , Castellanos L, González C.

Similar conferences about Medical and Health Sciences